Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer

Case Report: A 75-year-old man who underwent nivolumab as the third-line chemotherapy for advanced gastric cancer had chylous ascites (CA) after the primary tumor shrank remarkably. Total parenteral nutrition and subcutaneous octreotide were initiated, and CA disappeared. Nivolumab was continued for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: TOYOTA, SATOSHI, ORITA, HIROYUKI, FUKUYAMA, YASURO, MOTOYOSHI, SAKI, KAWANAMI, SHOGO, MAEDA, SHOHEI, KURAMITSU, ERINA, ICHIMANDA, MICHIHIRO, NAGAMATSU, SATOKO, NAGATA, SHIGEYUKI, KAI, SEIICHIRO, KORENAGA, DAISUKE, MORI, MASAKI
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157868/
https://ncbi.nlm.nih.gov/pubmed/32111756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11810
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados